Document is current
Any future updates will be listed below
-
Authors
Ishida, Hiroaki
Komaba, Hirotaka
Hamano, Naoto
Yamato, Hideyuki
Sawada, Kaichiro
Wada, Takehiko
Nakamura, Michio
Fukagawa, Masafumi
-
Funding
Funding for this research was provided by:
EA Pharma Co., Ltd.
- License Information
-
More Information
Article History
Received: 18 October 2019
Accepted: 24 February 2020
First Online: 5 March 2020
Compliance with ethical standards
:
: Dr. Komaba has received honoraria, consulting fees, and/or grant support from Bayer Yakuhin, Chugai Pharmaceutical, Japan Tobacco, Kyowa Kirin, Novartis, and Ono Pharmaceutical. Dr. Wada has received honoraria, consulting fees, and/or grant support from Chugai Pharmaceutical, Daiichi Sankyo, Kyowa Kirin, and Otsuka Pharmaceutical. Dr. Nakamura received grant support from Astellas Pharma and Novartis. Dr. Fukagawa has received honoraria, consulting fees, and/or grant support from Astellas Pharma, Bayer Yakuhin, EA Pharma Co., Ltd., Kissei Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, and Torii Pharmaceutical. The remaining authors declare no competing interests.
: All experiments were approved by the Institutional Review Board of Tokai University School of Medicine.
